Wien, 17 September 2024 – AR2-C2 GmbH, a leading initiative based in Germany dedicated to supporting Health Tech companies in navigating the European market, is pleased to announce a strategic partnership with Gold Ventures Investment (GVI), a prominent investment firm renowned for supporting high-potential startups.
This partnership aims to provide health tech startups with the regulatory, clinical, and reimbursement strategies they need to successfully enter the European market while optimizing their certification efforts.
Empowering Health Tech Startups with Regulatory and Clinical Strategies
AR2-C2’s team of experts provides hands-on guidance in regulatory, clinical, and reimbursement strategies, ensuring that startups can navigate the certification process efficiently. This comprehensive support enables health tech innovators to bring their products to market faster, with minimized risk and optimized compliance efforts.
Through the partnership, GVI brings its extensive investment expertise and startup ecosystem experience to complement AR2-C2’s regulatory capabilities. By leveraging GVI’s network of investors and business development resources, startups not only receive regulatory and clinical guidance but also gain access to financial backing and strategic partnerships. This dual support optimizes their market entry, accelerates their growth, and improves their chances of long-term success in the European health tech market.
Statements from the CEOs
“We are excited to collaborate with GVI to offer comprehensive support to health tech startups as they navigate the complexities of the European market. GVI’s strong investment network and startup expertise, combined with our deep regulatory, clinical, and reimbursement knowledge, create a powerful partnership that maximizes the success of these companies. Together, we can help health tech innovators bring their groundbreaking solutions to market more efficiently and with greater impact.” said Nika Mendelev, CEO of AR2-C2.
Kobi Kalderon, CEO of Gold Ventures Investment, added, “Our partnership with AR2-C2 is a powerful combination of regulatory know-how and investment expertise. Together, we are helping startups optimize their certification and business development processes, paving the way for successful market entry.”
About AR2-C2
AR2-C2 is an initiative focused on helping HealthTech companies successfully enter the European market by optimizing their regulatory, clinical, and reimbursement strategies. With a team of experts specializing in CE MDR and IVDR certification, clinical strategy, business development, quality management systems, and authorized representative and importer services, AR2-C2 provides hands-on support that maximizes the chances of success for health tech startups.
About Gold Ventures Investment (GVI)
Gold Ventures Investment is a leading investment firm with a focus on supporting startups across multiple sectors, including health tech. With a proven track record of helping startups secure investment and navigate market entry, GVI offers the financial and strategic guidance that early-stage companies need to scale and succeed.
Contact Information:
If you are a startup or investor who is interested in partnering with us, please contact us
We are happy to invite you to the German-Israeli Investment Forum: Innovations in Israeli HealthTech, an exclusive event thatwill be held on October 21 aimed at raising awareness and highlighting the investment opportunities within the Israeli startup scene.
for more information click on the Link
Comments